Image-guided helical tomotherapy for localized prostate cancer: Technique and initial clinical observations

Journal of Applied Clinical Medical Physics

Volumn 8, Issue 3, 2007, Pages 37-51

  Ramsey, Chester R ^a,b   Scaperoth, Daniel ^a   Seibert, Rebecca ^a,b   Chase, Daniel ^a   Byrne, Thomas ^a   Mahan, Stephen ^a  

^a THOMPSON CANCER SURVIVAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Helical tomotherapy; Image guided radiation therapy; Intensity modulation; Prostate

Indexed keywords

EID: 34548226395     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v8i3.2320     Document Type: Article

References (45)

1. Cox JA, Zagoria RJ, Raben M. Prostate cancer: comparison of retrograde urethrography and computed tomography in radiotherapy planning. Int J Radiat Oncol Biol Phys. 1994;29(5):1119-1123.
2. van Herk M, Bruce A, Guss Krose AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 1995;33(5):1311-1320.
3. Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33(5):1321-1329.
4. Crook JM, Raymond Y, Salhani D, Yang H, Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol. 1995;37(1):35-42.
5. Beard CJ, Kijewski P, Bussiere M, et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys. 1996;34(2):451-459.
6. Rudat V, Schraube P, Oetzel D, Zierhut D, Flentje M, Wannenmacher M. Combined error of patients positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1996;35(5):1027-1034.
7. Yan D, Ziaja E, Jaffray D, et al. The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. Int J Radiat Oncol Biol Phys. 1998;41(3):715-720.
8. Padhani AR, Khoo VS, Suckling J, et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys. 1999;44(3):525-533.
9. Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48(1):289-302.
10. Little DJ, Dong L, Levy LB, Chandra A, Kuban D. Use of portal images to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys. 2003;56(5):1218-1224.
11. Trichter F, Ennis RD. Prostate localization using transabdominal ultrasound imaging. Int J Radiat Oncol Biol Phys. 2003;56(5):1225-1233.
12. Court LE, Dong L, Taylor N, et al. Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study. Int J Radiat Oncol Biol Phys., 2004;59(2):412-418.
13. Chung PWM, Haycocks T, Brown T, et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 2004;60(1):329-334.
14. Smitsmans MHP, Wolthaus JWH, Artignan X, et al. Automatic localization of the prostate for on-line or off-line image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(2):623-635.
15. Ghilezan M, Yan D, Liang J, Jaffray D, Wong J, Martinez A. Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncot Biol Phys. 2004;60(5):1602-1610.
16. Court LE, Dong L, Lee AK, et al. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;62(1):154-163.
17. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005;62(2):406-417.
18. Kupelian PA, Willoughby TR, Meeks SL, et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys. 2005;62(5):1291-1296.
19. Létourneau D, Martinez AA, Lockman D, et al. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients. Int J Radiat Oncol Biol Phys. 2005;62(4):1239-1246.
20. Langen KM, Zhang Y, Andrews RD, et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys. 2005;62(5):1517-1524.
21. Litzenberg DW, Balter JM, Lam KL, Sandler HM, Ten Haken RK. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys. 2005;63(1):123-133.
22. Vargas C, Yan D, Kestin LL, et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys. 2005;63(1):141-149.
23. Balter JM, Wright JN, Newell LJ, et al. Accuracy of a wireless localization system for radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(3):933-937.
24. Smitsmans MHP, de Bois J, Sonke JJ, et al. Automatic prostate localization on cone-beam CT scans for high precision image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(4):975-984.
25. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept of the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20(6):1709-1719.
26. Yang, JN, Mackie TR, Reckwerdt PJ, Deasy JO, Thomadsen BR. An investigation of tomotherapy beam delivery. Med Phys. 1997;24(3):425-436.
27. Kapatoes JM, Olivera GH, Rechwerdt PJ, Fitchard EE, Schloesser EA, Mackie TR. Delivery verification in sequential and helical tomotherapy. Phys Med Biol. 1999;44(7):1815-1841.
28. Balog JP, Mackie TR, Reckwerdt P, Glass M, Angelos L. Characterization for the output for helical delivery of intensity modulated slit beams. Med Phys. 1999;26(1):55-64.
29. Ruchala KJ, Olivera GH, Kapatoes JM, Schloesser EA, Reckwerdt PJ, Mackie TR. Megavoltage CT image reconstruction during tomotherapy treatments. Phys Med Biol. 2000;45(12):3545-3562.
30. Mahan SL, Ramsey CR, Scaperoth SS, Chase DJ, Byrne TE. Evaluation of image-guided helical tomotherapy for the re-treatment of spinal metastasis. Int J Radiat Oncol Biol Phys. 2005;63(5):1576-1583.
31. Kupelian PA, Ramsey CR, Meeks SL, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small cell lung cancer: observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005;63(4):1024-1028.
32. Kupelian PA, Langen KM, Zeidan OA, et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66(3):876-882.
33. Michalski JM, Purdy JA, Winter K, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 2000;46(2):391-402.
34. Ryu JK, Winter K, Michalski JM, et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys. 2002;54(4):1036-1046.
35. Kestin LL, Goldstein NS, Vicini FA, Yan D, Korman HJ, Martinez A.A. Treatment of prostate cancer with radio-therapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys. 2002;54(3):686-697.
36. Roach M, DeSilvio M, Thomas CR, et al. Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): a subset analysis of RTOG 9413, a phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT). Int J Radiat Oncol Biol Phys, 2004;60(1 Suppl):S264-S265.
37. Roach M 3rd, DeSilvio M, Valicenti R, et al. Whole-pelvis, "mini-pelvis," or prostate-only external beam radio-therapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys. 2006;66(3):647-653.
38. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II): volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 2001;49(3):685-698.
39. Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys. 2001;51(4):988-993.
40. Ruchala KJ, Olivera GH, Kapatoes JM. Limited-data image registration for radiotherapy positioning and verification. Int J Radiat Oncol Biol Phys. 2002;54(2):592-605.
41. Nederveen AJ, Heide UA, Dehnad H, Moorselaar RJ, Hofman P, Lagendijk JJW. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 2002;53(1):206-214.
42. Huang E, Dong L, Chandra A, et al. Intrafraction prostate motion during IMRT for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;53(2):261-269.
43. Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks GE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37(1):3-11.
44. Crevoisier R, Tucher SL, Dong L, et al. Increased risk of biochemical and local failure in patients with distended recturn on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62(4):965-973.
45. Michalski JM, Winter & Purdy JA, et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys. 2005;62(3):706-713.